QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)

agilon health (AGL) Stock Price, News & Analysis

$6.06
+0.01 (+0.17%)
(As of 03/4/2024 ET)
Today's Range
$5.93
$6.15
50-Day Range
$5.70
$12.92
52-Week Range
$5.63
$29.44
Volume
3.56 million shs
Average Volume
6.80 million shs
Market Capitalization
$2.48 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$11.65

agilon health MarketRank™ Stock Analysis

Analyst Rating
Hold
2.31 Rating Score
Upside/​Downside
92.5% Upside
$11.65 Price Target
Short Interest
Bearish
15.41% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
-0.25mentions of agilon health in the last 14 days
Based on 32 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.30) to ($0.13) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.33 out of 5 stars

Medical Sector

775th out of 948 stocks

Miscellaneous Health & Allied Services, Not Elsewhere Classified Industry

6th out of 6 stocks


AGL stock logo

About agilon health Stock (NYSE:AGL)

agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2022, it served approximately 269,500 medicare advantage members and 89,000 Medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.

AGL Stock Price History

AGL Stock News Headlines

This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
agilon health (NYSE:AGL) PT Lowered to $9.00
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
agilon health inc. Q4 Earnings Summary
agilon health Reports Fourth Quarter 2023 Results
agilon health (NYSE:AGL) Downgraded by TD Cowen to "Market Perform"
TD Cowen Downgrades agilon health (AGL)
Analyst Expectations For Agilon Health's Future
Agilon Health Stock (NYSE:AGL) Insider Trades
See More Headlines
Receive AGL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for agilon health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/27/2024
Today
3/04/2024
Next Earnings (Estimated)
5/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
N/A
Fax
N/A
Employees
1,117
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$11.65
High Stock Price Target
$30.00
Low Stock Price Target
$6.00
Potential Upside/Downside
+92.5%
Consensus Rating
Hold
Rating Score (0-4)
2.31
Research Coverage
16 Analysts

Profitability

Net Income
$-262,600,000.00
Pretax Margin
-4.51%

Debt

Sales & Book Value

Annual Sales
$4.32 billion
Book Value
$1.63 per share

Miscellaneous

Free Float
396,027,000
Market Cap
$2.48 billion
Optionable
Not Optionable
Beta
0.49
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

  • Mr. Steven Jackson Sell (Age 58)
    President, CEO & Director
    Comp: $1.29M
  • Mr. Timothy S. Bensley (Age 63)
    Chief Financial Officer
    Comp: $831.31k
  • Mr. Girish Venkatachaliah (Age 50)
    Chief Technology Officer
    Comp: $655.04k
  • Mr. Ben Shaker (Age 41)
    Chief Markets Officer
    Comp: $715.5k
  • Mr. Veeral  DesaiMr. Veeral Desai (Age 43)
    Chief Strategy & Development Officer
    Comp: $667.58k
  • Mr. Timothy Gertsch (Age 38)
    VP, Controller & Chief Accounting Officer
  • Mr. Matthew Dale Gillmor CFA
    Vice President of Investor Relations
  • Ms. Denise Zamore
    Chief Legal Officer & Secretary
  • Ms. Claire Mulhearn
    Chief Communications & Public Affairs Officer
  • Mr. Mat Varghese
    Chief People Officer














AGL Stock Analysis - Frequently Asked Questions

Should I buy or sell agilon health stock right now?

16 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for agilon health in the last year. There are currently 11 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" AGL shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AGL, but not buy additional shares or sell existing shares.
View AGL analyst ratings
or view top-rated stocks.

What is agilon health's stock price target for 2024?

16 brokerages have issued 1-year target prices for agilon health's stock. Their AGL share price targets range from $6.00 to $30.00. On average, they anticipate the company's share price to reach $11.65 in the next year. This suggests a possible upside of 92.5% from the stock's current price.
View analysts price targets for AGL
or view top-rated stocks among Wall Street analysts.

How have AGL shares performed in 2024?

agilon health's stock was trading at $12.55 at the beginning of 2024. Since then, AGL stock has decreased by 51.8% and is now trading at $6.0550.
View the best growth stocks for 2024 here
.

Are investors shorting agilon health?

agilon health saw a decrease in short interest during the month of January. As of January 31st, there was short interest totaling 44,750,000 shares, a decrease of 5.8% from the January 15th total of 47,490,000 shares. Based on an average daily trading volume, of 5,190,000 shares, the short-interest ratio is currently 8.6 days. Approximately 15.0% of the company's stock are short sold.
View agilon health's Short Interest
.

When is agilon health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our AGL earnings forecast
.

How were agilon health's earnings last quarter?

agilon health, inc. (NYSE:AGL) released its earnings results on Tuesday, February, 27th. The company reported ($0.41) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.28) by $0.13. The business earned $1.06 billion during the quarter, compared to the consensus estimate of $1.02 billion. agilon health had a negative trailing twelve-month return on equity of 21.74% and a negative net margin of 5.76%. The business's quarterly revenue was up 71.8% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.14) EPS.

Is agilon health a good dividend stock?

agilon health (NYSE:AGL) pays an annual dividend of $1.80 per share and currently has a dividend yield of 0.00%.

What guidance has agilon health issued on next quarter's earnings?

agilon health updated its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $6.4 billion-$6.5 billion, compared to the consensus revenue estimate of $6.3 billion.

When did agilon health IPO?

(AGL) raised $1 billion in an IPO on Thursday, April 15th 2021. The company issued 46,600,000 shares at $20.00-$23.00 per share. J.P. Morgan, Goldman Sachs, BofA Securities, Deutsche Bank Securities and Wells Fargo Securities served as the underwriters for the IPO and William Blair, Truist Securities and Nomura were co-managers.

Who are agilon health's major shareholders?

agilon health's stock is owned by many different retail and institutional investors. Top institutional shareholders include Capital World Investors (13.60%), Vanguard Group Inc. (7.04%), Capital Research Global Investors (3.60%), Capital International Investors (2.69%), Price T Rowe Associates Inc. MD (2.50%) and Price T Rowe Associates Inc. MD (2.50%). Insiders that own company stock include Benjamin Kornitzer, Benjamin Shaker, Cd&R Investment Associates Ix,, Clay Richards, Glenn Sobotka, Jeffrey A Schwaneke, Joan Danieley, John William Wulf, Michael L Smith, Steven Sell, Theodore Halkias, Timothy Gertsch and Veeral Desai.
View institutional ownership trends
.

How do I buy shares of agilon health?

Shares of AGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:AGL) was last updated on 3/4/2024 by MarketBeat.com Staff